Such forward-looking statements include statements regarding, among other things, the expected initiation of a Phase 1 trial of RT-114 in 2025, the potential of the RaniPill platform to enable oral delivery of multiple obesity treatments and validation of such potential through preclinical data, the target product profile of semaglutide delivered via the RaniPill capsule, the novelty, convenience and attractiveness of a once-weekly oral semaglutide treatment for patients, Ranis confidence to continue building an obesity portfolio, the potential of a once-weekly oral version of semaglutide in the RaniPill capsule to deliver the same benefits as subcutaneous delivery and to impact patients lives, the sufficiency of Ranis cash reserves, and future financial performance
The clinical significance of delayed gastric emptying on single-dose emergency contraceptive absorption remains uncertain and has not been studied in controlled trials
This study identified a molecular target that is required to efficiently activate POMC neurons and control appetite. Finally, from May, Lipotoxicity Induces -cell Small Extracellular VesicleMediated -cell Dysfunction in Male Mice , is by Abhishek Roy, et al
L-carnitine ameliorates dyslipidemic and hepatic disorders induced by a high-fat diet via regulating lipid metabolism, self-antioxidant capacity, and inflammatory response Chang-Chao Sua, 1, Chaung-Sung Changb, Chung-Hsi Chouc, Yi-Hsieng Samuel Wub, Kuo-Tai Yangb, Jung-Kai Tsenge, Yuan-Yen Changf, Yi-Chen Chenb
Its safety profile is similar to existing incretin-based therapies, making it a particularly promising candidate for obesity, type 2 diabetes, and related metabolic conditions
